US 11891420
Molecules for organelle-specific protein delivery
granted A61KA61K38/00A61K47/64
Quick answer
US patent 11891420 (Molecules for organelle-specific protein delivery) held by Larimar Therapeutics, Inc. expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Larimar Therapeutics, Inc.
- Grant date
- Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K38/00, A61K47/64, A61P, A61P25/16